Matches in Wikidata for { <http://www.wikidata.org/entity/Q57083835> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q57083835 description "artículu científicu espublizáu en marzu de 2014" @default.
- Q57083835 description "im März 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57083835 description "scientific article published on 20 March 2014" @default.
- Q57083835 description "wetenschappelijk artikel" @default.
- Q57083835 description "наукова стаття, опублікована у 2014" @default.
- Q57083835 name "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 name "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 type Item @default.
- Q57083835 label "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 label "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 prefLabel "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 prefLabel "Neuropathological Characteristics of Progressionafter Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma" @default.
- Q57083835 P1433 Q57083835-0125AA69-32A9-41C6-819A-3A750B72FC72 @default.
- Q57083835 P1476 Q57083835-A9BC9D7A-5E37-4A4E-B75B-279C9B6473DA @default.
- Q57083835 P2093 Q57083835-44BFAC9F-4450-48EF-B720-E24BA6EF37E6 @default.
- Q57083835 P2093 Q57083835-4FD1064F-B054-40B7-B462-31A4E1B1D5DB @default.
- Q57083835 P2093 Q57083835-A4FEB8BB-7F11-4052-9B8C-8977B291318E @default.
- Q57083835 P304 Q57083835-664CB4ED-D496-4D99-AFE8-DCC8F1EB131C @default.
- Q57083835 P31 Q57083835-1F605FA5-BC67-4871-BC19-72B1C3AF7010 @default.
- Q57083835 P356 Q57083835-20F6B539-A45A-4162-9F63-86411ADDC259 @default.
- Q57083835 P433 Q57083835-CBB31373-B880-4C8B-A047-D78DF0E1B577 @default.
- Q57083835 P478 Q57083835-912D6D40-08A3-423E-A9C2-F1945987875F @default.
- Q57083835 P50 Q57083835-9106D7CF-9C36-4FBB-9CC2-7D95BC632311 @default.
- Q57083835 P50 Q57083835-EE1FD560-0104-4909-B4B5-74D3F5C83B9C @default.
- Q57083835 P577 Q57083835-6B2D5875-5591-47ED-85E9-15775BEA26D1 @default.
- Q57083835 P698 Q57083835-2AD71BAD-BDE1-4977-B74F-6ACBDE4505BE @default.
- Q57083835 P921 Q57083835-8A159C07-73C4-4113-9A40-8D22A531E6E9 @default.
- Q57083835 P921 Q57083835-CC72EA40-897F-4A38-A165-CC5EB4F97E76 @default.
- Q57083835 P356 000360780 @default.
- Q57083835 P698 24732646 @default.
- Q57083835 P1433 Q26842274 @default.
- Q57083835 P1476 "Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma" @default.
- Q57083835 P2093 "Elisabeth Rushing" @default.
- Q57083835 P2093 "Katharina Seystahl" @default.
- Q57083835 P2093 "Michael Weller" @default.
- Q57083835 P304 "209-212" @default.
- Q57083835 P31 Q13442814 @default.
- Q57083835 P356 "10.1159/000360780" @default.
- Q57083835 P433 "4" @default.
- Q57083835 P478 "37" @default.
- Q57083835 P50 Q37831548 @default.
- Q57083835 P50 Q55712288 @default.
- Q57083835 P577 "2014-03-20T00:00:00Z" @default.
- Q57083835 P698 "24732646" @default.
- Q57083835 P921 Q413299 @default.
- Q57083835 P921 Q460937 @default.